Gemcitabine and Monoclonal Antibody Therapy in Treating Patients With Metastatic Cancer of the Pancreas

PHASE2UnknownINTERVENTIONAL
Enrollment

41

Participants

Timeline

Start Date

March 31, 1999

Conditions
Pancreatic Cancer
Interventions
BIOLOGICAL

trastuzumab

DRUG

gemcitabine hydrochloride

Trial Locations (12)

10021

Memorial Sloan-Kettering Cancer Center, New York

10029

Mount Sinai Medical Center, NY, New York

60612

Rush-Presbyterian-St. Luke's Medical Center, Chicago

02111

New England Medical Center Hospital, Boston

02135-2997

St. Elizabeth's Medical Center, Boston

08903

Cancer Institute of New Jersey, New Brunswick

15213-3489

University of Pittsburgh Cancer Institute, Pittsburgh

02860

Memorial Hospital of Rhode Island, Pawtucket

02903

Rhode Island Hospital, Providence

02908-4735

Roger Williams Medical Center/BUSM, Providence

02912

Brown University Oncology Group, Providence

77030-4009

University of Texas - MD Anderson Cancer Center, Houston

Sponsors

Lead Sponsor

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Brown University

OTHER